Evidence map›Paper›PMID 36112647›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

ALS mutations in the TIA-1 prion-like domain trigger highly condensed pathogenic structures.

Naotaka Sekiyama, Kiyofumi Takaba, Saori Maki-Yonekura, Ken-Ichi Akagi, Yasuko Ohtani, Kayo Imamura, Tsuyoshi Terakawa, Keitaro Yamashita, Daigo Inaoka, Koji Yonekura and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. A coarse-grained model for disordered and multi-domain proteins.Protein science : a publication of the Protein Society · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Naotaka SekiyamaDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0003-4537-6565
Kiyofumi TakabaBiostructural Mechanism Laboratory, RIKEN SPring-8 Center, Sayo 679-5148, Japan.
Saori Maki-YonekuraBiostructural Mechanism Laboratory, RIKEN SPring-8 Center, Sayo 679-5148, Japan.
Ken-Ichi AkagiSection of Laboratory Equipment, National Institute of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.ORCID 0000-0002-7051-4598
Yasuko OhtaniDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.
Kayo ImamuraDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0002-2141-8495
Tsuyoshi TerakawaDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.
Keitaro YamashitaStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Daigo InaokaDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0002-8643-4031
Koji YonekuraBiostructural Mechanism Laboratory, RIKEN SPring-8 Center, Sayo 679-5148, Japan.ORCID 0000-0001-5520-4391
Takashi S KodamaDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0001-6820-1907
Hidehito TochioDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0003-3843-3330
Kyoto University · JPSPring-8 · JPJEOL (Japan) · JPMRC Laboratory of Molecular Biology · GBNational Institute of Biomedical Innovation, Health and Nutrition · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cell intracellular antigen-1 (TIA-1) plays a central role in stress granule (SG) formation by self-assembly via the prion-like domain (PLD). In the TIA-1 PLD, amino acid mutations associated with neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) or Welander distal myopathy (WDM), have been identified. However, how these mutations affect PLD self-assembly properties has remained elusive. In this study, we uncovered the implicit pathogenic structures caused by the mutations. NMR analysis indicated that the dynamic structures of the PLD are synergistically determined by the physicochemical properties of amino acids in units of five residues. Molecular dynamics simulations and three-dimensional electron crystallography, together with biochemical assays, revealed that the WDM mutation E384K attenuated the sticky properties, whereas the ALS mutations P362L and A381T enhanced the self-assembly by inducing β-sheet interactions and highly condensed assembly, respectively. These results suggest that the P362L and A381T mutations increase the likelihood of irreversible amyloid fibrillization after phase-separated droplet formation, and this process may lead to pathogenicity.

Indexed as

Amino AcidsAmyotrophic Lateral SclerosisPrionsProtein Aggregation, PathologicalT-Cell Intracellular Antigen-1Distal MyopathiesHumansMutationProtein Conformation, beta-StrandProtein DomainsAmino AcidsPrionsT-Cell Intracellular Antigen-1TIA1 protein, humanintrinsically disordered protein regionsliquid–liquid phase separationneurodegenerative diseases

Identifiers

PMID36112647
PMCPMC9499527
OpenAlexW4296036359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.